Device Pleural-Peritoneal Shunt

Automatic Continuous Effusion Shunt (Aces) System

Payments companies reported to CMS as associated with Automatic Continuous Effusion Shunt (Aces) System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$37Kassociated payments (2023-2025)
15clinicians with associated payments
1company reporting

By year

2025 $37K

Payments reported as associated with Automatic Continuous Effusion Shunt (Aces) System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Pulmonary Disease $26K
Internal Medicine $9,214
Thoracic Surgery (Cardiothoracic Vascular Surgery) $2,185
Diagnostic Radiology $139

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Automatic Continuous Effusion Shunt (Aces) System

These are the largest totals companies reported as associated with Automatic Continuous Effusion Shunt (Aces) System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Jason Akulian Baltimore, MD Pulmonary Disease $9,482.97
Jeffrey Thiboutot Baltimore, MD Internal Medicine $8,870.52
Lonny Yarmus Baltimore, MD Pulmonary Disease $8,474.76
Steven Leh Milwaukee, WI Pulmonary Disease $5,130.17
Fabien Maldonado Nashville, TN Pulmonary Disease $2,133.16
Mark Block Hollywood, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,925.55
Dylan Soller Allentown, PA Internal Medicine $224.37
Syed Razi Hollywood, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $140.00
Kevin Henseler Roseville, MN Diagnostic Radiology $138.78
Gaurav Ajmani Baltimore, MD Pulmonary Disease $119.50

Prescribed Automatic Continuous Effusion Shunt (Aces) System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.